Naturally Produced Enzyme May Be Useful In Inflammatory Arthritis
Ohio State UniversityResearchers have discovered a potential method to help treat inflammatory forms of arthritis by using an enzyme naturally produced by the human body.
Researchers have discovered a potential method to help treat inflammatory forms of arthritis by using an enzyme naturally produced by the human body.
The longer patients with kidney disease remain on dialysis before receiving a transplant, the more likely they are to die prematurely, new research shows.
Bungee cords, elastic devices used for securing equipment, can cause serious damage to the eye that may result in future vision problems if they are not used carefully.
IOWA CITY, Iowa -- A research team in the University of Iowa College of Medicine cautions physicians that the increasingly common practice of fathers videotaping births has both risks and benefits.
Surgeon General David Satcher today joined the AHCPR and ODPHP in urging clinicians, health plans and consumers to work together to make prevention--screening, immunizations and counseling for health behavior change--a part of every health care visit, in every clinical setting.
A life with cancer is often a life with pain. But it doesn't have to be that way. Physicians and multimedia designers at Michigan State University have developed a CD-ROM that addresses the issue of pain and cancer. Extremely interactive and visual, "Easing Cancer Pain" gives people with cancer the information they need to overcome their pain.
Several advances in the evaluation of regional lymph nodes, adjuvant therapy and genetic immunotherapy for the treatment of malignant melanoma have improved the treatment options for patients.
The direct cost of treating newly diagnosed melanoma in 1997, was estimated to be at least $563 million and may exceed $1 billion, according to findings from a new study.
Recent controversy over the role of sunscreens in preventing melanoma and skin cancer have raised questions about the use of these agents.
People are more motivated to examine their skin for skin cancer if they have had discussions with doctors and if they think they are at high risk for developing melanomas and other skin cancers according to a study published in the May, 1998, Journal of the American Academy of Dermatology.
In a groundbreaking study, the first direct cause and effect relationship between ultraviolet light and the development of melanoma was established according to research presented at the American Academy of DermatologyÃs Melanoma/Skin Cancer Detection and Prevention Month press conference on April 29.
Monday, May 4th, is the American Academy of DermatologyÃs (AAD) fourth annual Melanoma Monday. If detected early, melanoma, the deadliest form of skin cancer, has an excellent chance of being cured.
Americans have a one in 82 risk for developing melanoma in their lifetime, according to a 1997 study. In 1980, the risk was one in 250.
Johns Hopkins researchers have uncovered a simple way to predict which adult asthma patients are likely to run into asthma problems within the next year and possibly could benefit from different strategies to manage their disease.
New studies presented here at the American Lung Association/American Thoracic Society International Conference indicate that there are gender differences in the diagnosis, treatment and response to lung disease. Researchers described gender differences in three common lung diseases--asthma, chronic obstructive pulmonary disease and obstructive sleep apnea.
With violence in sports ever-present in the news -- players attacking coaches, unnecessary roughness in the Olympic women's hockey competition, even ear-bitting in boxing -- psychiatrists, coaches and players join a panel at the American Psychiatric Association's 151st Annual Meeting in Toronto, Ontario, Canada May 30 - June 4, 1998, at the Toronto Convention Centre.
Canadian and American psychiatric experts will share the latest research into the causes and treatments of mental illnesses at the American Psychiatric Association's 151st Annual Meeting in Toronto, Ontario, Canada May 30 - June 4, 1998, at the Toronto Convention Centre.
Addiction Research, Prevention and Treatment Released at APA 151st Annual Meeting in Toronto, Canada, May 30-June 4, 1998.
The Digital Holographyô System from VoxelÆ may be more cost-effective and reliable than frame-based stereotaxy for complex neurosurgeries, physicians will report this week at the annual meeting of the American Association of Neurological Surgeons (AANS).
The National Mental Health Association (NMHA) earned an A+ rating from the American Institute of Philanthropy (AIP), a non-profit charity watchdog and information service.
A whopping 97 percent of Mental Health Associations (MHAs) - affiliates of the National Mental Health Association - include mental health consumers and survivors in program planning and implementation, a new survey shows.
Chicago--The oral asthma controller therapy, Accolate (zafirlukast), from Zeneca Pharmaceuticals demonstrated significant improvements in quality-of-life scores in patients with moderate asthma, according to study data presented Monday at the American Lung Association/American Thoracic Society annual meeting.
Researchers have successfully treated Parkinsonism in rats by using fetal brain cells from cloned cows. This research is the first demonstration that transgenic cloned animal tissue can be used in the treatment of a disease. Results of the research study will appear in the May 1 issue of the journal Nature Medicine.
Why is my health coverage so limited for mental health? What is wrong with my child? Where can I go for help for anxiety disorders? During May, communities nationwide will be responding to these questions at health fairs, walks, workshops, screenings and other events. For members of the media, Mental Health Month offers a great opportunity to acquaint readers and listeners with important information on a variety of mental health topics.
"Formularies that restrict access to new psychotropic medications increase both treatment costs and the suffering of people with mental illnesses," said Michael Faenza, President and CEO of the National Mental Health Association. "They fail on economic and moral grounds."
A chemical associated with tuberculosis may substantially reduce the amount of damage sustained from a heart attack, a finding that could lead to new treatment for heart attack victims, according to a new study. The finding was made by two physician brothers in different disciplines who happened to discuss their individual research at a family gathering. Serendipity at its best.
Comprehensive Epilepsy Program Offers Two New Alternatives For Patients with Uncontrolled Seizures: "Awake" surgery and a new vagal nerve stimulation (VNS) pacemaker implant.
More solid evidence shows that growing up in a home around smokers has an adverse impact on lung function. The strongest correlation, highlighted in a new study, was with mothers who smoked. Girls seem to suffer more than boys, probably because girls spend more time around their mothers, researchers say.
Results from the primary phase of the first-ever human clinical trial of a vaccine genetically implanted inside a food indicate that consumption results in immunity to specific diseases. The test of the vaccine was made with vaccine-containing potatoes developed at the Boyce Thompson Institute for Plant Research Inc., (BTI) an affiliate of Cornell University. The human clinical study was conducted at the University of Maryland School of Medicine's Center for Vaccine Development in Baltimore.
DALLAS, April 28 -- Getting immediate vessel-opening treatment after a heart attack can help you live longer than previously believed, say researchers in a study published in today's Circulation: Journal of the American Heart Association.
DALLAS, April 28 -- Blood clots that can trigger a sudden heart attack often differ between men and premenopausal women -- a finding that may have important implications for preventing sudden cardiac death, which kills 250,000 people each year. This research was reported in a study in today's Circulation: Journal of the American Heart Association.
Inner-city residents frequently rely on the emergency room of their local hospital for asthma treatment, a practice that is not only expensive and inefficient but a sign that they are receiving insufficient help in managing the disease on their own. New research gives a detailed picture of these patients and the difficult challenges they pose.
Hospitalization and death rates due to asthma among African-American and Latino children in New York City are four times higher than the national average. One contributing factor may be the failure of families to recognize the nature of the disease and develop skills for managing it. In partnership with family physicians, a family coordinator can help families overcome an often passive attitude toward asthma and build confidence to try to prevent or minimize symptoms themselves. That is the finding of a new study.
Researchers at Harvard Medical School and the Center for Blood Research have identified a peptide that may serve as a template for a drug that can suppress the immune response with fewer side effects than immunosuppressants currently available. In addition to benefiting people who receive organ transplants, a drug based on this agent potentially could be used to treat chronic conditions caused by excessive or inappropriate immune responses, such as asthma, inflammation, allergies, and rheumatoid arthritis. Their findings are published in the April 24 Molecular Cell.
CHICAGO-April 27, 1998-In a new linical trial, 55 percent of asthma patients indicated that they preferred Accolate (zafirlukast), the nonsteroid tablet from Zeneca Pharmaceuticals, over the most commonly used inhaled corticosteroid, beclomethasone dipropionate (200 or 250 mcg bid).
Citing the tremendous advances in biology over the past 30 years and the extraordinary potential for the transformation of medical practice and human health,the Federation of American Societies for Experimental Biology (FASEB) urged a substantial increase in funding for the National Institutes of Health (NIH) and biomedical science.
Who ever thinks about swallowing? But a stroke, neck surgery, or old age can all make swallowing so difficult that some people need to be fed by a tube. Now a research team has found a way to use a simple exercise to improve people's ability to swallow - no surgery, no drugs.
Combined data from an analysis of five clinical studies show that the oral asthma controller therapy, Accolate" (zafirlukast), from Zeneca Pharmaceuticals may reduce the need for short courses of oral steroids in patients experiencing asthma attacks. The study results were presented today in an abstract at the American Lung Association/American Thoracic Society annual meeting in Chicago.
By delivering medicines to specific areas of the human body, peptides are expected to be a link for dramatic breakthroughs in the treatment of many diseases and illnesses, including Alzheimer's disease and HIV-related illnesses. Researchers at the University of Kansas are leaders in the fields of peptide and peptidomimetics research, a field that is growing in importance. (Story tip package from KU)
Contrary to conventional wisdom, aerobic exercise is a safe and effective way to improve the strength and cardiovascular fitness of stroke patients, even if they begin exercising six months or more after their stroke.
Temple University School of Medicine is now in the second year of a four-year, $3 million study to investigate chronic rejection and to determine whether donor bone marrow can "trick" recipients' immune systems into coexisting without rejection of the transplanted hearts.
Neuroscientists at the Yerkes Primate Research Center of Emory University have discovered in the brain a novel neurotransmitter that helps control food intake and seems to be partially responsible for the feeling of satiety. The finding may eventually be used to develop medications for obesity, a life-threatening, yet common condition that often lies at the root of other serious illnesses such as diabetes and cardiovascular disease. The study will be reported in the journal Synapse (vol 29, No. 4), available in May on the Synapse website.
Researchers who were looking for the reason why simple aspirin use protects some people from developing heart attacks have traced the mechanism back to a specific genetic factor present on the surface of clotting cells called platelets.
The National Cattlemen's Beef Association (NCBA) has just published an information resource about Creutzfeldt-Jakob Disease (classic CJD), Bovine Spongiform Encephalopathy (BSE) and new variant CJD (nvCJD).
A natural supplement may provide protection from heart attacks or strokes, especially for smokers or those with a history of heart disease, according to a breakthrough study in humans to be presented during the American Society for Biochemistry and Molecular Biology (ASBMB) annual meeting.
With the unlikely but invaluable help of an electron accelerator, University of Wisconsin Medical School molecular biologists have definitively shown for the first time that within the seven-some-feet of the folded chromosome in every cell nucleus, special repair proteins do their work by moving from their home bases to remote gene damage sites. The study is reported in the April 24 Science.
Surgeon General David Satcher and former Secretary of Labor Robert Reich will address the American Occupational Health Conference April 29, Hynes Convention Center, Boston. Nation's largest occupational health conference expects 8,000 attendees.
WALTHAM, Mass. -- An X-ray detector technology first developed at Brandeis University for use by structural biologists is now being used to produce speedy, high-resolution digital images of breast tissue that could replace standard mammograms as a screening technique.
As the U.S. Department of Agriculture begins to establish new dietary guidelines for the year 2000, a new University of Michigan study suggests low fat diets' are not always the most healthy.
A vaccine pairing a genetically altered, harmless canarypox virus, and a genetically engineered piece of the HIV protein coat, induce immune system activity against laboratory strains of HIV better than either vaccine alone, according to a Johns Hopkins School of Public Health researcher.